-
1
-
-
0032537396
-
Tamoxifen for early breast cancer: An overview of the randomized trials
-
Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer: an overview of the randomized trials. Lancet 1998;351:1451-67.
-
(1998)
Lancet
, vol.351
, pp. 1451-1467
-
-
-
2
-
-
0030941236
-
Tamoxifen: The herald of a new era of preventive therapeutics
-
Jordan VC. Tamoxifen: the herald of a new era of preventive therapeutics. J Natl Cancer Inst 1997;89:747-9.
-
(1997)
J Natl Cancer Inst
, vol.89
, pp. 747-749
-
-
Jordan, V.C.1
-
3
-
-
0032490068
-
Breast cancer prevention trial shows major benefit, some risk
-
Smigel K. Breast cancer prevention trial shows major benefit, some risk. J Natl Cancer Inst 1998;90:647-8.
-
(1998)
J Natl Cancer Inst
, vol.90
, pp. 647-648
-
-
Smigel, K.1
-
4
-
-
0028208456
-
Endometrial cancer in tamoxifen-treated breast cancer patients: Findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14
-
Fisher B, Costantino JP, Redmond CK, Fisher ER, Wickerham DL, Cronin WM. Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J Natl Cancer Inst 1994;86:527-37.
-
(1994)
J Natl Cancer Inst
, vol.86
, pp. 527-537
-
-
Fisher, B.1
Costantino, J.P.2
Redmond, C.K.3
Fisher, E.R.4
Wickerham, D.L.5
Cronin, W.M.6
-
5
-
-
0028898873
-
Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies
-
Stockholm Breast Cancer Study Group
-
Rutqvist LE, Johansson H, Signomklao T, Johansson U, Fornander T, Wilking N. Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group. J Natl Cancer Inst 1995;87:645-51.
-
(1995)
J Natl Cancer Inst
, vol.87
, pp. 645-651
-
-
Rutqvist, L.E.1
Johansson, H.2
Signomklao, T.3
Johansson, U.4
Fornander, T.5
Wilking, N.6
-
6
-
-
0028053224
-
Risk of endometrial cancer after tamoxifen treatment of breast cancer
-
van Leeuwen FE, Benraadt J. Coebergh JW, Kiemeney LA, Gimbrere CH, Otter R, et al. Risk of endometrial cancer after tamoxifen treatment of breast cancer. Lancet 1994;343: 448-52.
-
(1994)
Lancet
, vol.343
, pp. 448-452
-
-
Van Leeuwen, F.E.1
Benraadt, J.2
Coebergh, J.W.3
Kiemeney, L.A.4
Gimbrere, C.H.5
Otter, R.6
-
7
-
-
0027787754
-
Pharmacokinetics of anti-endocrine agents
-
Lonning PE, Lien EA. Pharmacokinetics of anti-endocrine agents. Cancer Sury 1993;17: 343-70.
-
(1993)
Cancer Sury
, vol.17
, pp. 343-370
-
-
Lonning, P.E.1
Lien, E.A.2
-
8
-
-
0020003085
-
Tamoxifen and metabolites in MCF7 cells: Correlation between binding to estrogen receptor and inhibition of cell growth
-
Coezy E, Borgna JL, Rochefort H. Tamoxifen and metabolites in MCF7 cells: correlation between binding to estrogen receptor and inhibition of cell growth. Cancer Res 1982;42: 317-23.
-
(1982)
Cancer Res
, vol.42
, pp. 317-323
-
-
Coezy, E.1
Borgna, J.L.2
Rochefort, H.3
-
9
-
-
0023621378
-
Mechanisms of growth inhibition by nonsteroidal antioestrogens in human breast cancer cells
-
Sutherland RL, Watts CK, Hall RE, Ruenitz PC. Mechanisms of growth inhibition by nonsteroidal antioestrogens in human breast cancer cells. J Steroid Biochem 1987;27:891-7.
-
(1987)
J Steroid Biochem
, vol.27
, pp. 891-897
-
-
Sutherland, R.L.1
Watts, C.K.2
Hall, R.E.3
Ruenitz, P.C.4
-
10
-
-
0028000253
-
Effects of tamoxifen on cardiovascular risk factors in postmenopausal women after 5 years of treatment
-
Love RR, Wiebe DA, Feyzi JM, Newcomb PA, Chappell RJ. Effects of tamoxifen on cardiovascular risk factors in postmenopausal women after 5 years of treatment. J Natl Cancer Inst 1994;86:1534-9.
-
(1994)
J Natl Cancer Inst
, vol.86
, pp. 1534-1539
-
-
Love, R.R.1
Wiebe, D.A.2
Feyzi, J.M.3
Newcomb, P.A.4
Chappell, R.J.5
-
11
-
-
0029791115
-
Effect of tamoxifen on measurements of hemostasis in healthy women
-
Mannucci PM, Bettega D, Chantarangkul V, Tripodi A, Sacchini V, Veronesi U.. Effect of tamoxifen on measurements of hemostasis in healthy women. Arch Intern Med 1996;156: 1806-10.
-
(1996)
Arch Intern Med
, vol.156
, pp. 1806-1810
-
-
Mannucci, P.M.1
Bettega, D.2
Chantarangkul, V.3
Tripodi, A.4
Sacchini, V.5
Veronesi, U.6
-
12
-
-
0026519891
-
Antithrombin III level, fibrinogen level and platelet count changes with adjuvant tamoxifen therapy
-
Love RR, Surawicz TS, Williams EC. Antithrombin III level, fibrinogen level and platelet count changes with adjuvant tamoxifen therapy. Arch Intern Med 1992;152:317-20.
-
(1992)
Arch Intern Med
, vol.152
, pp. 317-320
-
-
Love, R.R.1
Surawicz, T.S.2
Williams, E.C.3
-
13
-
-
0026585852
-
Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer
-
Love RR, Mazess RB, Barden HS, Epstein S, Newcomb PA, Jordan VC, et al. Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer. N Engl J Med 1992;326:852-6.
-
(1992)
N Engl J Med
, vol.326
, pp. 852-856
-
-
Love, R.R.1
Mazess, R.B.2
Barden, H.S.3
Epstein, S.4
Newcomb, P.A.5
Jordan, V.C.6
-
14
-
-
0024539364
-
Effect of tamoxifen on plasma insulin-like growth factor I in patients with breast cancer
-
Coletti RB, Roberts JD, Devlin JT, Copeland KC. Effect of tamoxifen on plasma insulin-like growth factor I in patients with breast cancer. Cancer Res 1989;49:1882-4.
-
(1989)
Cancer Res
, vol.49
, pp. 1882-1884
-
-
Coletti, R.B.1
Roberts, J.D.2
Devlin, J.T.3
Copeland, K.C.4
-
15
-
-
0025611672
-
Effect of tamoxifen on serum insulinlike growth factor I levels in stage I breast cancer patients
-
Pollak M, Costantino J, Polychronakos C, Blauer SA, Guyda H, Redmond C, et al. Effect of tamoxifen on serum insulinlike growth factor I levels in stage I breast cancer patients. J Natl Cancer Inst 1990;82:1693-7.
-
(1990)
J Natl Cancer Inst
, vol.82
, pp. 1693-1697
-
-
Pollak, M.1
Costantino, J.2
Polychronakos, C.3
Blauer, S.A.4
Guyda, H.5
Redmond, C.6
-
16
-
-
0032508293
-
Prevention of breast cancer with tamoxifen: Preliminary findings from the Italian randomised trial among hysterectomised women
-
Italian Tamoxifen Prevention Study
-
Veronesi U, Maisonneuve P, Costa A, Sacchini V, Maltoni C, Robertson C, et al. Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study. Lancet 1998;352:93-7.
-
(1998)
Lancet
, vol.352
, pp. 93-97
-
-
Veronesi, U.1
Maisonneuve, P.2
Costa, A.3
Sacchini, V.4
Maltoni, C.5
Robertson, C.6
-
17
-
-
0022908915
-
Stability of total cholesterol, high-density-lipoprotein cholesterol, and triglycerides in frozen sera
-
Stokes YM, Salmond CE, Carpenter LM, Weby TJ. Stability of total cholesterol, high-density-lipoprotein cholesterol, and triglycerides in frozen sera. Clin Chem 1986;32:995-9.
-
(1986)
Clin Chem
, vol.32
, pp. 995-999
-
-
Stokes, Y.M.1
Salmond, C.E.2
Carpenter, L.M.3
Weby, T.J.4
-
18
-
-
17344377231
-
-
WHO Expert Committee on specifications for pharmaceutical preparations. World Health Organ Tech Rep Ser 1996;863:1-194.
-
(1996)
World Health Organ Tech Rep Ser
, vol.863
, pp. 1-194
-
-
-
19
-
-
0027948506
-
A prospective investigation of elevated lipoprotein (a) detected by electrophoresis and cardiovascular disease in women
-
The Framingham Heart Study
-
Bostom AG, Gagnon DR, Cupples LA, Wilson PW, Jenner JL, Ordovas JM, et al. A prospective investigation of elevated lipoprotein (a) detected by electrophoresis and cardiovascular disease in women. The Framingham Heart Study. Circulation 1994;90:1688-95.
-
(1994)
Circulation
, vol.90
, pp. 1688-1695
-
-
Bostom, A.G.1
Gagnon, D.R.2
Cupples, L.A.3
Wilson, P.W.4
Jenner, J.L.5
Ordovas, J.M.6
-
20
-
-
0026497082
-
Automated measurement of lipoprotein(a) by immunoturbidimetric analysis
-
Levine DM, Sloan BJ, Donner JE, Lorenz JD, Heinzerling RH. Automated measurement of lipoprotein(a) by immunoturbidimetric analysis. Int J Clin Lab Res 1992;22:173-8.
-
(1992)
Int J Clin Lab Res
, vol.22
, pp. 173-178
-
-
Levine, D.M.1
Sloan, B.J.2
Donner, J.E.3
Lorenz, J.D.4
Heinzerling, R.H.5
-
21
-
-
0015348189
-
Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
-
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
-
(1972)
Clin Chem
, vol.18
, pp. 499-502
-
-
Friedewald, W.T.1
Levy, R.I.2
Fredrickson, D.S.3
-
22
-
-
0028031664
-
Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro
-
Garnero P, Grimaux M, Seguin P, Dehnas PD. Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro. J Bone Miner Res 1994;9:255-64.
-
(1994)
J Bone Miner Res
, vol.9
, pp. 255-264
-
-
Garnero, P.1
Grimaux, M.2
Seguin, P.3
Dehnas, P.D.4
-
23
-
-
0018959529
-
Inhibition of access of bound somatomedin to membrane receptor and immunobinding sites: A comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol-extracted serum
-
Daughaday WH, Mariz IK, Blethen SL. Inhibition of access of bound somatomedin to membrane receptor and immunobinding sites: a comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol-extracted serum. J Clin Endocrinol Metab 1980;51:781-8.
-
(1980)
J Clin Endocrinol Metab
, vol.51
, pp. 781-788
-
-
Daughaday, W.H.1
Mariz, I.K.2
Blethen, S.L.3
-
24
-
-
0025689891
-
An analysis of randomized trials evaluating the effect of cholesterol reduction on total mortality and coronary heart disease incidence
-
Holme I. An analysis of randomized trials evaluating the effect of cholesterol reduction on total mortality and coronary heart disease incidence. Circulation 1990;82:1916-24.
-
(1990)
Circulation
, vol.82
, pp. 1916-1924
-
-
Holme, I.1
-
25
-
-
0027249160
-
Tamoxifen-induced decrease in total cholesterol with 2 weeks of treatment
-
Love RR, Mamby CC, Feyzi JM. Tamoxifen-induced decrease in total cholesterol with 2 weeks of treatment. J Natl Cancer Inst 1993; 85:1344-5.
-
(1993)
J Natl Cancer Inst
, vol.85
, pp. 1344-1345
-
-
Love, R.R.1
Mamby, C.C.2
Feyzi, J.M.3
-
26
-
-
0026472377
-
Intact and amino-terminally shortened forms of insulin-like growth factor I induce mammary gland differentiation and development
-
Ruan W, Newman CB, Kleinberg DL. Intact and amino-terminally shortened forms of insulin-like growth factor I induce mammary gland differentiation and development. Proc Natl Acad Sci U S A 1992;89:10872-6.
-
(1992)
Proc Natl Acad Sci U S A
, vol.89
, pp. 10872-10876
-
-
Ruan, W.1
Newman, C.B.2
Kleinberg, D.L.3
-
27
-
-
0025641592
-
Role of estrogen-induced insulin-like growth factors in the proliferation of human breast cancer cells
-
van der Burg B, Isbrucker L, van Selm-Miltenburg AJ, de Laat SW, van Zoelen EJ. Role of estrogen-induced insulin-like growth factors in the proliferation of human breast cancer cells. Cancer Res 1990;50:7770-4.
-
(1990)
Cancer Res
, vol.50
, pp. 7770-7774
-
-
Van Der Burg, B.1
Isbrucker, L.2
Van Selm-Miltenburg, A.J.3
De Laat, S.W.4
Van Zoelen, E.J.5
-
28
-
-
0024460381
-
Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice
-
Arteaga CL, Kitten LJ, Coronado EB, Jacobs S, Kull FC Jr, Allred DC, et al. Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice. J Clin Invest 1989;84:1418-23.
-
(1989)
J Clin Invest
, vol.84
, pp. 1418-1423
-
-
Arteaga, C.L.1
Kitten, L.J.2
Coronado, E.B.3
Jacobs, S.4
Kull Jr., F.C.5
Allred, D.C.6
-
29
-
-
0027454914
-
Plasma insulin-like growth factor-1 (IGF-1) concentrations in human breast cancer
-
Peyrat J,. Bonneterre J, Hecquet B, Vennin P, Louchez MM, Fournier C, et al. Plasma insulin-like growth factor-1 (IGF-1) concentrations in human breast cancer. Eur J Cancer 1993; 29A:492-7.
-
(1993)
Eur J Cancer
, vol.29 A
, pp. 492-497
-
-
Peyrat, J.1
Bonneterre, J.2
Hecquet, B.3
Vennin, P.4
Louchez, M.M.5
Fournier, C.6
-
30
-
-
0029129747
-
Insulin-like growth-factor-binding protein 3 is decreased in early-stage operable pre-menopausal breast cancer
-
Bruning PF, Van Doom J, Bonfrer JM, Van Noord PA, Korse CM, Linders TC, et al. Insulin-like growth-factor-binding protein 3 is decreased in early-stage operable pre-menopausal breast cancer. Int J Cancer 1995;62:266-70.
-
(1995)
Int J Cancer
, vol.62
, pp. 266-270
-
-
Bruning, P.F.1
Van Doom, J.2
Bonfrer, J.M.3
Van Noord, P.A.4
Korse, C.M.5
Linders, T.C.6
-
31
-
-
0032499440
-
Circulating concentration of insulin-like growth factor-I and risk of breast cancer
-
Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B, et al. Circulating concentration of insulin-like growth factor-I and risk of breast cancer. Lancet 1998;351:1393-6.
-
(1998)
Lancet
, vol.351
, pp. 1393-1396
-
-
Hankinson, S.E.1
Willett, W.C.2
Colditz, G.A.3
Hunter, D.J.4
Michaud, D.S.5
Deroo, B.6
-
34
-
-
0028893618
-
Approaches to the development and marketing approval of drugs that prevent cancer
-
Kelloff GJ, Johnson JR, Crowell JA, Boone CW, DeGeorge JJ, Steele VE, et al. Approaches to the development and marketing approval of drugs that prevent cancer. Cancer Epidemiol Biomarkers Prev 1995;4:1-10.
-
(1995)
Cancer Epidemiol Biomarkers Prev
, vol.4
, pp. 1-10
-
-
Kelloff, G.J.1
Johnson, J.R.2
Crowell, J.A.3
Boone, C.W.4
DeGeorge, J.J.5
Steele, V.E.6
-
35
-
-
0000147542
-
Recent advances in chemoprevention of cancer
-
Hong WK, Sporn MB. Recent advances in chemoprevention of cancer. Science 1997;278: 1073-7.
-
(1997)
Science
, vol.278
, pp. 1073-1077
-
-
Hong, W.K.1
Sporn, M.B.2
-
36
-
-
0030899189
-
Effects of chronic administration of tamoxifen and toremifene on DNA adducts in rat liver, kidney, and uterus
-
Li D, Dragan Y, Jordan VC, Wang M, Pitot HC. Effects of chronic administration of tamoxifen and toremifene on DNA adducts in rat liver, kidney, and uterus. Cancer Res 1997; 57:1438-41.
-
(1997)
Cancer Res
, vol.57
, pp. 1438-1441
-
-
Li, D.1
Dragan, Y.2
Jordan, V.C.3
Wang, M.4
Pitot, H.C.5
-
37
-
-
0029745072
-
Tamoxifcn-induced DNA adducts in endometrial samples from breast cancer patients
-
Hemminki K, Rajaniemi H, Lindhal B, Moberger B. Tamoxifcn-induced DNA adducts in endometrial samples from breast cancer patients. Cancer Res 1996;56:4374-7.
-
(1996)
Cancer Res
, vol.56
, pp. 4374-4377
-
-
Hemminki, K.1
Rajaniemi, H.2
Lindhal, B.3
Moberger, B.4
-
38
-
-
0030033914
-
Effect of tamoxifen on endometrial proliferation
-
Decensi A, Fontana V, Bruno S, Gustavino S, Gatteschi B, Costa A. Effect of tamoxifen on endometrial proliferation. J Clin Oncol 1996; 14:434-40.
-
(1996)
J Clin Oncol
, vol.14
, pp. 434-440
-
-
Decensi, A.1
Fontana, V.2
Bruno, S.3
Gustavino, S.4
Gatteschi, B.5
Costa, A.6
-
39
-
-
0027994593
-
Established risk factors and coronary artery disease: The Framingham Study
-
Wilson PW. Established risk factors and coronary artery disease: the Framingham Study. Am J Hypertens 1994;7:7S-12S.
-
(1994)
Am J Hypertens
, vol.7
-
-
Wilson, P.W.1
-
40
-
-
0025812175
-
Blood platelet count and function are related to total and cardiovascular death in apparently healthy men
-
Thaulow E, Erikssen J, Sandvik L, Stormorken H, Cohn PF. Blood platelet count and function are related to total and cardiovascular death in apparently healthy men. Circulation 1991;84: 613-7.
-
(1991)
Circulation
, vol.84
, pp. 613-617
-
-
Thaulow, E.1
Erikssen, J.2
Sandvik, L.3
Stormorken, H.4
Cohn, P.F.5
-
41
-
-
0027479505
-
White blood cell count, coronary heart disease, and death: The NHANES I Epidemiologic Follow-up Study
-
Gillum RF, Ingram DD, Makuc DM. White blood cell count, coronary heart disease, and death: the NHANES I Epidemiologic Follow-up Study. Am Heart J 1993;125:855-63.
-
(1993)
Am Heart J
, vol.125
, pp. 855-863
-
-
Gillum, R.F.1
Ingram, D.D.2
Makuc, D.M.3
-
42
-
-
0032503554
-
Effect of fenretinide on plasma IGF-I and IGFBP-3 in early breast cancer patients
-
Torrisi R, Parodi S, Fontana V, Pensa F, Casella C, Barreca A, et al. Effect of fenretinide on plasma IGF-I and IGFBP-3 in early breast cancer patients. Int J Cancer 1998;76:787-90.
-
(1998)
Int J Cancer
, vol.76
, pp. 787-790
-
-
Torrisi, R.1
Parodi, S.2
Fontana, V.3
Pensa, F.4
Casella, C.5
Barreca, A.6
-
43
-
-
8244264298
-
Hypocholesterolemic activity of raloxifene (LY139481): Pharmacological characterization as a selective estrogen receptor modulator
-
Kauffman RF, Bensch WR, Roudebush RE, Cole HW, Bean JS, Phillips DL, et al. Hypocholesterolemic activity of raloxifene (LY139481): pharmacological characterization as a selective estrogen receptor modulator. J Pharmacol Exp Ther 1997;280:146-53.
-
(1997)
J Pharmacol Exp Ther
, vol.280
, pp. 146-153
-
-
Kauffman, R.F.1
Bensch, W.R.2
Roudebush, R.E.3
Cole, H.W.4
Bean, J.S.5
Phillips, D.L.6
-
45
-
-
0029038734
-
Ligand-dependent repression of the erythroid transcription factor GATA-1 by the estrogen receptor
-
Blobel GA, Sieff CA, Orkin SH, Ligand-dependent repression of the erythroid transcription factor GATA-1 by the estrogen receptor. Mol Cell Biol 1995;15:3147-53.
-
(1995)
Mol Cell Biol
, vol.15
, pp. 3147-3153
-
-
Blobel, G.A.1
Sieff, C.A.2
Orkin, S.H.3
-
47
-
-
0028803064
-
Menopause is associated with a significant increase in blood monocyte number and a relative decrease in the expression of estrogen receptors in human peripheral monocytes
-
Ben-Hur H, Mor G, Insler V, Blickstein I, Amir-Zaltsman Y, Sharp A, et al. Menopause is associated with a significant increase in blood monocyte number and a relative decrease in the expression of estrogen receptors in human peripheral monocytes. Am J Reprod Immunol 1995;34:363-9.
-
(1995)
Am J Reprod Immunol
, vol.34
, pp. 363-369
-
-
Ben-Hur, H.1
Mor, G.2
Insler, V.3
Blickstein, I.4
Amir-Zaltsman, Y.5
Sharp, A.6
-
48
-
-
0028286272
-
Estrogen regulation of the insulin-like growth factor 1 gene transcription involves an AP-1 enhancer
-
Umayahara Y, Kawamori R, Watada H, Imano E, Iwama N, Morishima T, et al. Estrogen regulation of the insulin-like growth factor 1 gene transcription involves an AP-1 enhancer. J Biol Chem 1994;269:16433-42.
-
(1994)
J Biol Chem
, vol.269
, pp. 16433-16442
-
-
Umayahara, Y.1
Kawamori, R.2
Watada, H.3
Imano, E.4
Iwama, N.5
Morishima, T.6
-
49
-
-
0028129023
-
The Royal Marsden Hospital pilot tamoxiten chemoprevention trial
-
Powles TJ, Jones AL, Ashley SE, O'Brien ME, Tidy VA, Treleavan J, et al. The Royal Marsden Hospital pilot tamoxiten chemoprevention trial. Breast Cancer Res Treat 1994;31: 73-82.
-
(1994)
Breast Cancer Res Treat
, vol.31
, pp. 73-82
-
-
Powles, T.J.1
Jones, A.L.2
Ashley, S.E.3
O'Brien, M.E.4
Tidy, V.A.5
Treleavan, J.6
-
50
-
-
0029451354
-
Tamoxifen's role in chemoprevention of breast cancer: An update
-
Nayfield SG. Tamoxifen's role in chemoprevention of breast cancer: an update. J Cell Biochem Suppl 1995;22:42-50.
-
(1995)
J Cell Biochem Suppl
, vol.22
, pp. 42-50
-
-
Nayfield, S.G.1
-
51
-
-
3543123425
-
Tamoxifen used as a chemopreventative agent lowers serum IGF-I levels
-
Pollak M, Powles TJ, Baum M, Sacks N. Tamoxifen used as a chemopreventative agent lowers serum IGF-I levels [abstract]. Proc Am Assoc Cancer Res 1993;34:255.
-
(1993)
Proc Am Assoc Cancer Res
, vol.34
, pp. 255
-
-
Pollak, M.1
Powles, T.J.2
Baum, M.3
Sacks, N.4
-
52
-
-
0027229625
-
Suppression of serum insulin-like growth factor-1 levels in breast cancer patients during adjuvant tamoxifen therapy
-
Friedl A, Jordan VC, Pollak M. Suppression of serum insulin-like growth factor-1 levels in breast cancer patients during adjuvant tamoxifen therapy. Eur J Cancer 1993;29A:1368-72.
-
(1993)
Eur J Cancer
, vol.29 A
, pp. 1368-1372
-
-
Friedl, A.1
Jordan, V.C.2
Pollak, M.3
-
53
-
-
0002997892
-
Experimental results on the chemopreventive and side effects of tamoxifen using a human-equivalent animal model
-
Maltoni C, Soffritti M, Davis W, editors. Amsterdam: Elsevier Sciences
-
Maltoni C, Minardi F, Belpoggi F, Pinto C, Lenzi A, Filippini F. Experimental results on the chemopreventive and side effects of tamoxifen using a human-equivalent animal model. In: Maltoni C, Soffritti M, Davis W, editors. The scientific bases of cancer chemoprevention. Amsterdam: Elsevier Sciences; 1996. p. 197-217.
-
(1996)
The Scientific Bases of Cancer Chemoprevention
, pp. 197-217
-
-
Maltoni, C.1
Minardi, F.2
Belpoggi, F.3
Pinto, C.4
Lenzi, A.5
Filippini, F.6
-
54
-
-
0029994748
-
Raloxifene, tamoxifen, nafoxidine, or estrogen effects on reproductive and nonreproductive tissues in ovariectomized rats
-
Sato M, Rippy MK, Bryant HU. Raloxifene, tamoxifen, nafoxidine, or estrogen effects on reproductive and nonreproductive tissues in ovariectomized rats. FASEB J 1996;10: 905-12.
-
(1996)
FASEB J
, vol.10
, pp. 905-912
-
-
Sato, M.1
Rippy, M.K.2
Bryant, H.U.3
-
55
-
-
0031013929
-
Comparative effects of droloxifene, tamoxifen and estrogen on bone, serum cholesterol, and uterine histology in the ovariectomized rat model
-
Ke HZ, Chen HK, Simmons HA, Qi H, Crawford DT, Pirie CM, et al. Comparative effects of droloxifene, tamoxifen and estrogen on bone, serum cholesterol, and uterine histology in the ovariectomized rat model. Bone 1997; 20:31-9.
-
(1997)
Bone
, vol.20
, pp. 31-39
-
-
Ke, H.Z.1
Chen, H.K.2
Simmons, H.A.3
Qi, H.4
Crawford, D.T.5
Pirie, C.M.6
-
56
-
-
0025936010
-
Alteration of endocrine parameters in premenopausal women with breast cancer during long-term adjuvant therapy with tamoxifen as the single agent
-
Jordan VC, Fritz NF, Langan-Fahey S, Thompson M, Tormey DC. Alteration of endocrine parameters in premenopausal women with breast cancer during long-term adjuvant therapy with tamoxifen as the single agent. J Natl Cancer Inst 1991;83:1488-91.
-
(1991)
J Natl Cancer Inst
, vol.83
, pp. 1488-1491
-
-
Jordan, V.C.1
Fritz, N.F.2
Langan-Fahey, S.3
Thompson, M.4
Tormey, D.C.5
-
57
-
-
0024506261
-
A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive -mors
-
Fisher B, Costantino J, Redmond C, Poisson R, Bowman D, Couture J, et al. A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive -mors. N Engl J Med 1989;320:479-84.
-
(1989)
N Engl J Med
, vol.320
, pp. 479-484
-
-
Fisher, B.1
Costantino, J.2
Redmond, C.3
Poisson, R.4
Bowman, D.5
Couture, J.6
-
58
-
-
0025996176
-
Symptoms associated with tamoxifen treatment in postmenopausal women
-
Love RR, Cameron L, Connell BL, Leventhal H. Symptoms associated with tamoxifen treatment in postmenopausal women. Arch Intern Med 1991;151:1842-7.
-
(1991)
Arch Intern Med
, vol.151
, pp. 1842-1847
-
-
Love, R.R.1
Cameron, L.2
Connell, B.L.3
Leventhal, H.4
-
59
-
-
0030664688
-
Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women
-
Delmas PD, Bjarnason NH, Mitlak BH, Ravoux AC, Shah AS, Huster WJ, et al. Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. N Engl J Med 1997;337:1641-7 [see comments in: Fileihan GE. Tissue-specific estrogens - the promise for the future. N Engl J Med 1997;337: 1686-7].
-
(1997)
N Engl J Med
, vol.337
, pp. 1641-1647
-
-
Delmas, P.D.1
Bjarnason, N.H.2
Mitlak, B.H.3
Ravoux, A.C.4
Shah, A.S.5
Huster, W.J.6
-
60
-
-
0030685047
-
Tissue-specific estrogens - The promise for the future
-
Delmas PD, Bjarnason NH, Mitlak BH, Ravoux AC, Shah AS, Huster WJ, et al. Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. N Engl J Med 1997;337:1641-7 [see comments in: Fileihan GE. Tissue-specific estrogens - the promise for the future. N Engl J Med 1997;337: 1686-7].
-
(1997)
N Engl J Med
, vol.337
, pp. 1686-1687
-
-
Fileihan, G.E.1
|